» Authors » Michal Chojnicki

Michal Chojnicki

Explore the profile of Michal Chojnicki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 128
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gozdziewicz L, Tobis S, Chojnicki M, Wieczorowska-Tobis K, Neumann-Podczaska A
Healthcare (Basel) . 2024 Aug; 12(15). PMID: 39120255
In the original publication [...].
2.
Rzepinski T, Deskur-Smielecka E, Chojnicki M
Am J Bioeth . 2024 Jun; 24(7):51-53. PMID: 38913480
No abstract available.
3.
Gozdziewicz L, Tobis S, Chojnicki M, Wieczorowska-Tobis K, Neumann-Podczaska A
Healthcare (Basel) . 2024 Feb; 12(3). PMID: 38338218
The COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) is a patient-reported outcome measure designed to assess the long-term effects of COVID-19. The scale was validated and is commonly used in the general...
4.
Gozdziewicz L, Tobis S, Chojnicki M, Chudek J, Wieczorowska-Tobis K, Idasiak-Piechocka I, et al.
Med Sci Monit . 2023 Aug; 29:e941197. PMID: 37583130
BACKGROUND Long-term care facilities were severely impacted during the COVID-19 (Coronavirus Disease 2019) pandemic. Residents surviving the disease might continue to suffer from the post-COVID syndrome, similar to community-dwelling persons....
5.
de Mezer M, Rogalinski J, Przewozny S, Chojnicki M, Niepolski L, Sobieska M, et al.
Biomedicines . 2023 Jan; 11(1). PMID: 36672665
SERPINA3, also called α-1-antichymotrypsin (AACT, ACT), is one of the inhibitors of serine proteases, one of which is cathepsin G. As an acute-phase protein secreted into the plasma by liver...
6.
Chojnicki M, Neumann-Podczaska A, Seostianin M, Tomczak Z, Tariq H, Chudek J, et al.
Int J Environ Res Public Health . 2021 Oct; 18(20). PMID: 34682421
Older adults are particularly susceptible to COVID-19 in terms of both disease severity and risk of death. To compare clinical differences between older COVID-19 hospitalized survivors and non-survivors, we investigated...
7.
Rzymski P, Pazgan-Simon M, Simon K, Lapinski T, Zarebska-Michaluk D, Szczepanska B, et al.
Vaccines (Basel) . 2021 Aug; 9(7). PMID: 34358197
The clinical trials of the COVID-19 vaccines that are authorized in the European Union have revealed high efficacy in preventing symptomatic infections. However, during vaccination campaigns, some vaccine recipients, including...
8.
Neumann-Podczaska A, Chojnicki M, Karbowski L, Al-Saad S, Hashmi A, Chudek J, et al.
Int J Environ Res Public Health . 2020 Nov; 17(22). PMID: 33198124
The older population is one of the most vulnerable to experience adverse outcomes of COVID-19. Exploring different clinical features that may act as detrimental to this population's survival is pivotal...
9.
Neumann-Podczaska A, Al-Saad S, Karbowski L, Chojnicki M, Tobis S, Wieczorowska-Tobis K
Aging Dis . 2020 Aug; 11(4):988-1008. PMID: 32765959
The SARS-CoV-2 tendency to affect the older individuals more severely, raises the need for a concise summary isolating this age population. Analysis of clinical features in light of most recently...
10.
Deskur-Smielecka E, Sopata M, Chojnicki M, Sopata M
BMJ Support Palliat Care . 2019 Jun; 12(e2):e178-e180. PMID: 31201154
Spontaneous enterocutaneous fistulae are a rare complication in patients with cancer, especially following irradiation, chemotherapy or cytoreductive operations. They are associated with worse prognosis, higher costs of treatment and impaired...